| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $50.50B | $60.76B | $59.60B | $60.07B | $52.44B |
| Cost of Revenue | $26.79B | $33.39B | $34.43B | $35.91B | $30.26B |
| Gross Profit | $23.71B | $27.37B | $25.18B | $24.17B | $22.18B |
| Operating Expenses | – | – | – | – | – |
| R&D | $836.00M | $987.00M | $949.00M | $908.00M | – |
| SG&A | $13.62B | $16.19B | $15.24B | $14.48B | $12.55B |
| Operating Income | $9.04B | $9.40B | $9.76B | $10.76B | $8.70B |
| Interest Expense | $1.02B | $1.11B | $1.04B | $818.00M | $491.00M |
| Tax Expense | $2.48B | $2.50B | $2.20B | $2.07B | $1.94B |
| Net Income | $10.01B | $6.37B | $7.14B | $8.27B | $6.62B |
| EPS (basic) | 4.3300 | 2.3000 | 2.5800 | 3.0000 | 2.3300 |
| EPS (diluted) | 4.3200 | 2.2900 | 2.5600 | 2.9900 | 2.3200 |
| Shares (diluted) | $2.20B | $2.51B | $2.53B | $2.56B | $2.61B |